Channel

TREND IMMUNOLOGY

@Trend_Immunology

On this record: Growth · Engagement · Reactions · Posts · Citations · Cite this entry

469subscribers

-2 since we began measuring on 6 August 2026

Risers and fallers across the register · movement among entries of Under 1,000.

Register entry

Telegram ID	-1001329521223
Type	Channel
Username	@Trend_Immunology
Created	Between 1 March 2018 and 31 July 2021— estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded	6 August 2026
Last confirmed live	15 August 2026
Measurements held	3
Confirmed unchanged	1 time, most recently 15 August 2026
On Telegram	t.me/Trend_Immunology

Growth

3 measurements spanning 9 days, net -2. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 469–471 and does not start at zero.

Measurement log — every subscribers count we have recorded
Measured (UTC)	Subscribers	Change
15 Aug 2026, 14:17	469	-2
6 Aug 2026, 19:02	471	no change
6 Aug 2026, 15:18	471	first reading

Engagement

20 posts held, back to 31 December 2023 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 pageof Telegram’s post history, 20 posts per page.

Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 6 July 2024. An engagement rate over an empty window would be a number about nothing.

Reaction mix

45 reactions across 15 posts, in 3 distinct kinds. The most used accounts for 60.0% of them.

Every reaction kind recorded on the sample, most used first
Reaction	Count	Share
👍	27	60.0%
❤	10	22.2%
🔥	8	17.8%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 16 of the 20 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 45reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 20 most recent posts we hold, published 31 December 2023 to 6 July 2024, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

6 Jul 2024, 20:10 UTC≈1,910 views4 reactionsread 6 August 2026

Photo

📢 مرکز تحقیقات ایمونولوژی دانشگاه علوم پزشکی ایران برگزار می‌کند: 📌کارگاه «اصول و مبانی ایمونوفلورسانس» 📆 23 تیر 1403 🕗 ساعت 12-9 به صورت حضوری 📍مکان: گروه ایمونولوژی دانشگاه علوم پزشکی ایران، طبقه اول 👩🏻‍🏫 مدرس: جناب آقای دکتر علی اکبر دلبندی 💳هزینه: دانشجویان دانشگاه علوم پزشکی ایران 50 هزار تومان ثبت نام عمومی: 100 هزار تومان 📑 همراه با صدور گواهی معتبر از معاونت تحقیقات و فناوری دانشگاه علوم پزشکی ایران …

🔥3👍1

Signed Pooya Farhangnia

5 Jun 2024, 19:57 UTC≈1,260 views3 reactionsread 6 August 2026

Current and future immunotherapeutic approaches in pancreatic cancer treatment 🔴New Paper by IMMUNO-TACT USERN Interest Group 🌀 Immunotherapy has revolutionized the treatment of pancreatic cancer, yet its effectiveness is limited by the tumor's immunosuppressive and hard-to-reach microenvironment. 🌀 This article explains the immunosuppressive microenvironment of pancreatic cancer and highlights a wide range of imm…

❤3

Signed Pooya Farhangnia

3 May 2024, 09:06 UTC≈1,270 views5 reactionsread 6 August 2026

Vitamin D and reproductive disorders: a comprehensive review with a focus on endometriosis 🔴New Paper by IMMUNO-TACT USERN Interest Group 🌀 Vitamin D deficiency has been identified as a risk factor for infertility, gonadal cancers, pregnancy complications, polycystic ovary syndrome, and endometriosis. 🌀 Data investigating the association between vitamin D levels and reproductive disorders, including endometriosis,…

👍4❤1

Signed Pooya Farhangnia

9 Apr 2024, 11:33 UTC≈1,340 views2 reactionsread 6 August 2026

🔴در این مطالعه، سه شرکت‌کننده مبتلا به گلیوبلاستوما عودکننده با سلول‌های T CARv3-TEAM-E تحت درمان قرار گرفتند که آنتی‌ژن‌های خاص روی تومورها را هدف قرار می‌دهند. این درمان عوارض جانبی شدیدی ایجاد نکرد و منجر به پسرفت تومور قابل توجه در مدت کوتاهی پس از انفوزیون شد، اگرچه پاسخ‌ها در دو نفر از شرکت‌کنندگان موقتی بود. @Trend_Immunology @Immunology_Board @Sabaflow @Usern_Net

❤1👍1

Signed Pooya Farhangnia

8 Apr 2024, 16:29 UTC≈1,090 views3 reactionsread 6 August 2026

🔴یک مطالعه جدید نشان داد که استفاده از یک پلتفرم ویرایش RNA CRISPR به نام MEGA می تواند سلول-درمانی سرطان را با اصلاح RNA سلول های ایمنی برای بهبود توانایی آنها در هدف قرار دادن تومورها افزایش دهد. این پلتفرم اجازه می دهد تا تغییرات برگشت پذیر در بیان ژن در سلول های T بدون تغییر دائمی در DNA انجام شود. با تنظیم ژن های دخیل در متابولیک در سلول های T، محققان توانستند عملکرد ضد تومور را بهبود بخشند و پایداری را در حمله…

🔥2❤1

Signed Pooya Farhangnia

6 Apr 2024, 09:12 UTC423 viewsread 6 August 2026

Forwarded from @SabaFlowPhoto

"فلوسایتومتری" مهم ترین تغییر ۱۴۰۳ میتونه باشه برات. 💪 ۵ روز ورکشاپ عملی فلوسایتومتری + سرفصل‌های اضافه شده در سال ۱۴۰۳ 🔺آموزش عملی با ۲ دستگاه متفاوت (آنالوگ و دیجیتال) و نرم افزار آن‌ها 🔺مقدمه‌ای بر Full Spectrum Flow Cytometry 🔺آموزش تیتراسیون آنتی بادی و نحوه محاسبه Separtion Index 🔺آموزش نصب پلاگین‌های FLowJo 10 و اتصال به زبان R 🔺آموزش کنترل کیفیت (QC) و نرمالایز کردن دیتا جهت آنالیز پیشرفته با دیتای 10 رنگ…

Signed Pouria Ghiaee

17 Mar 2024, 20:01 UTC≈1,010 views2 reactionsread 6 August 2026

Photo

🔴 جهت تهیه کتاب می‌توانید با شماره 09196805842 تماس حاصل فرمایید.

👍2

Signed Pooya Farhangnia

13 Mar 2024, 08:28 UTC≈1,050 views0 reactionsread 6 August 2026

🔴The Moslehi laboratory and UCSF Section of Cardio-Oncology & Immunology is recruiting post-doctoral candidates interested in studying the immune basis for inflammatory cardiac diseases. 🔴Email me if interested: [email protected]

Signed Pooya Farhangnia

11 Mar 2024, 13:48 UTC≈1,140 views2 reactionsread 6 August 2026

🔴محققان یک کارآزمایی فاز I/II را برای ارزیابی Pivekimab sunirine (IMGN632)، یک کونژوگه آنتی‌بادی-دارو بر ضد مولکول CD123، در بیماران مبتلا به لوسمی حاد میلوئیدی عودکننده یا مقاوم به درمان (AML) که با بیان بالای CD123 مشخص شده است، انجام دادند. این مطالعه دوز توصیه شده فاز II را 0.045 میلی گرم به ازای هر کیلوگرم از وزن بدن هر سه هفته یک بار، با نرخ پاسخ کلی 21٪ و نرخ بهبود کامل ترکیبی 17٪ تعیین کرد. این درمان با عوارض…

👍2

Signed Pooya Farhangnia

30 Jan 2024, 15:29 UTC≈1,090 views5 reactionsread 6 August 2026

Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma 🔴New Paper by IMMUNO-TACT USERN Interest Group 🌀 Pancreatic cancer is a truculent disease with limited treatment options and a grim prognosis. Immunotherapy has shown promise in treating various types of cancer, but its effectiveness in pancreatic cancer has been lacking. 🌀 The IH…

❤2👍2🔥1

Signed Pooya Farhangnia

17 Jan 2024, 18:36 UTC474 views3 reactionsread 6 August 2026

🔴حضور سلول های CD8+ T در سرطان پستان تریپل نگاتیو (TNBC) محدود است و با نتایج ضعیف و مقاومت در برابر Immune checkpoint blockade (ICB) همراه است. فاکتور رونویسی Stat3 در ایجاد یک محیط سرکوب کننده سیستم ایمنی نقش دارد و فقدان آن در تومورهای سینه موش منجر به کاهش بیان سایتوکاین Chi3l1 می شود. TNBCهای انسانی و سایر تومورها با حضور محدود سلول T سطوح بالای Chi3l1 را نشان دادند. حذف Chi3l1 در یک مدل سرطان سینه منجر به پاسخ …

🔥2❤1

Signed Pooya Farhangnia

16 Jan 2024, 17:58 UTC998 views5 reactionsread 6 August 2026

🔴محققان Mayo Clinic مکانیسم های مولکولی را کشف کرده اند که تعیین می کند کدام سلول های آلوده به HIV می میرند و کدامیک زنده می مانند. این مطالعه نشان می دهد که پروتئینی به نام Casp8p41 باعث مرگ سلول های آلوده به HIV می شود، اما می تواند توسط پروتئین انسانی به نام Bcl2 خنثی شود و به سلول های آلوده اجازه زنده ماندن و تکثیر می دهد. با درک این فرآیند، محققان توانستند یک مهارکننده Bcl2 بسازند که توانایی از بین بردن سلول‌های…

👍5

Signed Pooya Farhangnia

Showing the 12 most recent of 20 posts we hold for @Trend_Immunology. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Citation-graph rank

Citation-graph rank — 869,434 of 1,481,243entries in the measured graph. A weighted position computed from the forward and mention edges below — republished posts weigh more than named mentions — and recomputed periodically, over the whole graph. Published only as this ordinal position, never as a score: a position is a fact, and a score printed beside one channel’s name would read as a verdict this register does not make. The two counts beneath stay separate for the same reason mentions are never summed with forwards anywhere else on this page — a named-by count costs nothing to manufacture. The top 100 by this measure, or how it is computed.

Forward network

Republished by

Channels on the register that have forwarded this channel's posts into their own feed.

Advanced Lectures in Clinical Immunology & Cellular Therapeutics
@immunology_board · 8253 posts

Republishes

Channels on the register whose posts this channel has forwarded.

Sababiomedicals | فلوسایتومتری
@SabaFlow · 8,2911 post

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Named by 1 registered channel — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.

Named by

Channels on the register whose posts name this channel's handle.

Advanced Lectures in Clinical Immunology & Cellular Therapeutics
@immunology_board · 8253 posts

Names

Channels on the register whose handles appear in this channel's posts.

Sababiomedicals | فلوسایتومتری
@SabaFlow · 8,29117 posts Advanced Lectures in Clinical Immunology & Cellular Therapeutics
@immunology_board · 82516 posts USERN
@usern_net · 11,54916 posts

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 15 August 2026 — this entry's latest reading, not the date you are reading this.

“TREND IMMUNOLOGY” (@Trend_Immunology), 469 subscribers as measured 15 August 2026. Telegram Register, tgregister.com/channel/Trend_Immunology.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.